Provenance du réseau au premier degré de David Zeng
Entité | Type d'entité | Industrie | |
---|---|---|---|
BaroFold, Inc.
BaroFold, Inc. Pharmaceuticals: MajorHealth Technology BaroFold, Inc. develops and commercializes protein therapeutics. Its services include protein refolding, protein analytical and aggregate characterization, formulation stability and immunogenicity studies, and microbial expression. The company was founded by Matthew Seefeldt, Matthew Brewer, John F. Carpenter, Ted Randolph, Timothy C. Rodell, and Lyndal K. Hesterberg in 2009 and is headquartered in Aurora, CO.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à David Zeng via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal | |
American Chemical Society
American Chemical Society Miscellaneous Commercial ServicesCommercial Services American Chemical Society engages as a scientific society which supports scientific inquiry in the field of chemistry. The company was founded in 1876 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Massachusetts Institute of Technology | College/University | Doctorate Degree | |
University of California, Davis | College/University | Undergraduate Degree | |
Ilypsa, Inc.
Ilypsa, Inc. BiotechnologyHealth Technology Ilypsa, Inc. operates a biopharmaceutical firm. It develops renal care pharmaceutical products. The company was founded on March 6, 2003 and is headquartered in Thousand Oaks, CA. | Biotechnology | Chief Executive Officer | |
American Association for the Advancement of Science
American Association for the Advancement of Science Miscellaneous Commercial ServicesCommercial Services The American Association for the Advancement of Science provides science related journal, program, and education services. The firm also promotes the responsible use of science in public policy. The company was founded in 1848 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
American Institute of Chemical Engineers
American Institute of Chemical Engineers Miscellaneous Commercial ServicesCommercial Services The American Institute of Chemical Engineers (AIChE) is a professional society with over 60,000 members in more than 110 countries. The private company is based in New York, NY, and has subsidiaries in the United States. AIChE offers various programs, including e-learning, webinars, and career advancement, to help chemical engineers at every career juncture bridge the skills gap created by the rush of technology, changing work styles, and unprecedented societal needs. Founded in 1908, AIChE is a focal point for information exchange on the frontiers of chemical engineering research in areas such as energy, sustainability, biological and environmental engineering, nanotechnology, and chemical plant safety and security. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
The Controlled Release Society
The Controlled Release Society Miscellaneous Commercial ServicesCommercial Services The Controlled Release Society is a private company that focuses on providing fundamental delivery research, development, regulatory science, and clinical translation. The company is based in St. Paul, MN. The company was founded by Agis Kydonieus. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Exicure Operating Co.
Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL. | Pharmaceuticals: Major | Director/Board Member | |
Ashvattha Therapeutics Inc
Ashvattha Therapeutics Inc Pharmaceuticals: MajorHealth Technology Ashvattha Therapeutics LLC provides healthcare services. The firm develops pharmaceutical products. The company is headquartered in Redwood City, CA. | Pharmaceuticals: Major | Chief Executive Officer | |
Orpheris, Inc.
Orpheris, Inc. BiotechnologyHealth Technology Orpheris, Inc. provides healthcare services. The firm focused on the treatment of neuroinflammatory orphan diseases. The company was founded was founded in 2015 and is headquartered in Redwood City, CA. | Biotechnology | Founder | |
EXICURE, INC. | Biotechnology | Director/Board Member | |
Elixirgen Therapeutics, Inc.
Elixirgen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elixirgen Therapeutics, Inc. operates as a biotechnology company. It develops and sells stem cell therapies for genetic diseases. The company was founded by Akihiro Ko and Minoru S. H. Ko in 2017 and is headquartered in Baltimore, MD. | Pharmaceuticals: Major | Director/Board Member | |
ImmunSYS, Inc.
ImmunSYS, Inc. Pharmaceuticals: MajorHealth Technology ImmunSYS, Inc. is a clinical stage biopharmaceutical company focused on the development of cancer immunotherapy products. The company was founded by Eamonn P. Hobbs and Charles J. Link Jr. in March 2018 and is headquartered in Fort Lauderdale, FL. | Pharmaceuticals: Major | Director/Board Member | |
Syncromune, Inc.
Syncromune, Inc. Pharmaceuticals: MajorHealth Technology Syncromune, Inc. is a clinical-stage biopharmaceutical company that is dedicated to developing an in situ platform technology optimized for metastatic solid tumor cancers. The company is based in Fort Lauderdale, FL. The company is currently developing Sync-T™, a novel combination drug/device treatment platform that aims to achieve high response rates with potentially curative efficacy. The therapy is designed to synchronize in situ neoantigen T cell education and immunostimulation via intratumoral/locoregional infusion, with the goal of enabling the immune system to recognize and attack cancer throughout the body. The first two candidates, SV-101 and SV-102, are currently in investigator-initiated phase 1 trials. Link. The company was founded in 2020 by Charles J. Eamonn P. Hobbs has been the CEO of the company since 2020. | Pharmaceuticals: Major | Director/Board Member |
Statistiques
Internationale
Etats-Unis | 21 |
Sectorielle
Health Technology | 14 |
Commercial Services | 5 |
Finance | 2 |
Consumer Services | 2 |
Health Services | 2 |
Opérationnelle
Director/Board Member | 9 |
Corporate Officer/Principal | 6 |
Chief Executive Officer | 5 |
Founder | 4 |
President | 4 |
Relations les plus connectées
Insiders | |
---|---|
Jeffrey L. Cleland | 21 |
- Bourse
- Insiders
- David Zeng
- Connexions Sociétés